Physicochemical Properties, Toxicity, and Specific Activity of a Follitropin Alpha Biosimilar


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Comparative analysis of the primary structure of recombinant human follicle-stimulating hormone (r-hFSH) in samples of follitropin alpha biosimilar (FAB) preparation and the reference drug Gonal-F showed they were identical while spectral analysis of their secondary and tertiary structures indicated they were bioequivalent. Analytical results for N-glycans and sialic acids revealed that the main glycan structures were similar and the distributions of the main forms of sialic acids in the compared samples differed insignificantly. Results of in vitro and in vivo biological activity testing confirmed that FAB and Gonal-F were equivalent with respect to WHO standards. Comparative testing of the acute and subacute toxicity did not reveal significant differences between the two drugs and also confirmed they were identical. Thus, the investigation proved that FAB and the reference drug were equivalent with respect to the main physicochemical, pharmacodynamic, and toxicological characteristics.

Об авторах

I. Vorob’ev

Federal Research Centre for Fundamentals of Biotechnology, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
Россия, 33 – 2 Leninskii Prosp., Moscow, 119071

O. Proskurina

All-Russia Scientific Center for Safety Testing of Biologically Active Substances, Ministry of Public Health of the Russian Federation

Email: mikhail.polzikov@gmail.com
Россия, 23 Kirov St., Staraya Kupavna, Noginskii District, Moscow Oblast, 142450

Yu. Khodak

Federal Research Centre for Fundamentals of Biotechnology, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
Россия, 33 – 2 Leninskii Prosp., Moscow, 119071

A. Gosudarev

N. F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Russian Ministry of Health

Email: mikhail.polzikov@gmail.com
Россия, 18 Gamaleya St., Moscow, 123098

A. Semikhin

N. F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Russian Ministry of Health

Email: mikhail.polzikov@gmail.com
Россия, 18 Gamaleya St., Moscow, 123098

D. Byrikhina

N. F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Russian Ministry of Health

Email: mikhail.polzikov@gmail.com
Россия, 18 Gamaleya St., Moscow, 123098

M. Krasil’shchikova

Shemyakin—Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
Россия, 16/10 Miklukho-Maklaya St., Moscow, 117997

B. Mel’nik

Institute of Protein Research, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
Россия, 4 Institutskaya St., Pushchino, Moscow Oblast, 142290

M. Serebryakova

A. N. Belozersky Institute of Physicochemical Biology, Moscow State University

Email: mikhail.polzikov@gmail.com
Россия, 1/40 Leninskie Gory, Moscow, 119992

M. Polzikov

IVPharma Co.

Автор, ответственный за переписку.
Email: mikhail.polzikov@gmail.com
Россия, 20/2 Nauchnyi Proezd, Moscow, 117246

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media New York, 2017

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).